Hidden Profits During 10-K Filing Season Don’t Always Lead to a Good Stock
This week’s Filing Season Finds report highlights AstraZeneca (AZN) for understating its profits by $1.1 billion (16% of GAAP earnings)
Kyle Guske II, Senior Investment Analyst, MBA